Respiratory Tract Diseases

Search with Google Search with Bing
Information
Disease name
Respiratory Tract Diseases
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05944770 Active, not recruiting N/A ASPIRE Health Tulare County July 29, 2023 October 31, 2023
NCT04170348 Active, not recruiting Phase 2 Daily Vitamin D for Sickle-cell Respiratory Complications September 15, 2020 February 28, 2025
NCT05622942 Active, not recruiting Phase 1 Clinical Trial of Recombinant Pneumococcal Protein Vaccine March 11, 2023 December 11, 2023
NCT02871856 Active, not recruiting N/A International Lung Screen Trial (ILST) April 5, 2017 December 2025
NCT00377338 Completed Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases May 2006 June 2013
NCT00382408 Completed Phase 3 A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001 September 2006 December 2007
NCT00743990 Completed N/A Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough October 2008 March 2010
NCT00962455 Completed Phase 4 Feedback Reports and e-Learning in Primary Care Spirometry November 2007 April 2009
NCT00975572 Completed Phase 2 Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older July 2009 February 2010
NCT00984945 Completed Phase 1 Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults September 2009 July 2010
NCT01033487 Completed Phase 2 A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease January 2010 June 2010
NCT01244867 Completed Phase 2 Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine November 2010 September 2011
NCT01264055 Completed Cross-sectional Characterization of Idiopathic Bronchiectasis April 26, 2011
NCT01295255 Completed Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients February 2009 November 2009
NCT01295866 Completed Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation January 2010 November 2010
NCT01507415 Completed Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD? November 2011 February 2014
NCT00122057 Completed N/A Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis June 2005 June 2007
NCT00197691 Completed Botswana Pediatric Respiratory Disease and Bloodstream Infection Study March 2001 October 2005
NCT00254956 Completed Phase 3 Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma January 2004 June 2005
NCT01442779 Completed Phase 2 Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis September 2000 May 2007
NCT00011310 Completed Cardiopulmonary Effects of Particulate Exposure March 1999 February 2002
NCT01587131 Completed Phase 1 DNA-based Influenza Vaccine in the Elderly June 2012 March 2015
NCT01649193 Completed What is an Important Change in the Short Physical Performance Battery (SPPB)? March 2012 May 2014
NCT01710644 Completed Phase 1/Phase 2 Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis May 2013 August 2014
NCT01786681 Completed N/A Use of Positive Pressure in Morbidly Obese Patients Undergoing Reduction Stomach Surgery August 2011 December 2011
NCT01860898 Completed N/A A Phase I Study of iPS Cell Generation From Patients With COPD September 2009 October 28, 2014
NCT01872663 Completed N/A Influence of Different Physical Therapy Resources Application After Reduction Stomach Surgery August 2013 December 2013
NCT01991561 Completed Phase 2 Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. June 2013 November 2014
NCT01991587 Completed Phase 1/Phase 2 Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults October 8, 2013 June 30, 2014
NCT02022163 Completed Phase 1 Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. December 2013 December 2014
NCT02093936 Completed Lymphocytes Cut Off Values of Induced Sputum Samples in Healthy and Non-healthy Patients- A Cross Sectional Study January 2005
NCT02113072 Completed Phase 3 Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics. April 2014 November 2014
NCT02162576 Completed N/A Asthma Data Innovation Demonstration Project June 2012 January 2014
NCT02198391 Completed Study of Echinaforce Junior Tablets in Children With Acute Colds October 15, 2014 August 7, 2015
NCT02233816 Completed Phase 2 Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults July 28, 2014 June 22, 2015
NCT02236052 Completed Phase 2 Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population July 16, 2014 June 17, 2015
NCT02298517 Completed N/A Application Breathing Exercises With Load Inspiratory Postoperative Abdominal Surgery December 2013 December 2014
NCT02352168 Completed N/A Airway Inflammation in Children With Allergic Rhinitis and Intervention September 2014 October 2015
NCT02477293 Completed Phase 4 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine August 2015 January 2016
NCT02768805 Completed Phase 2 Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults March 2, 2016 November 26, 2016
NCT02831751 Completed Phase 2 Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults April 2016 January 2017
NCT03301051 Completed Phase 3 Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults August 31, 2017 May 9, 2018
NCT03401463 Completed N/A Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar October 26, 2017 July 5, 2018
NCT03433729 Completed N/A Patient Agenda Setting and Clinic Efficiency in Outpatients March 2014 May 2014
NCT03443479 Completed Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure April 1, 2015 July 1, 2019
NCT03688074 Completed Phase 2 Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) November 2, 2018 November 16, 2020
NCT03739112 Completed Phase 3 Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly September 18, 2018 July 16, 2019
NCT03764319 Completed N/A Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO November 6, 2018 August 1, 2021
NCT03843541 Completed Phase 3 A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions June 25, 2019 February 5, 2021
NCT03874520 Completed N/A Using Video Transmission for Telephone Triage of Children February 25, 2019 March 31, 2020
NCT04087460 Completed Early Phase 1 Phase Ⅰa Clinical Trial of a Pneumococcal Vaccine April 10, 2020 June 30, 2022
NCT04822818 Completed Phase 3 EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 April 17, 2021 July 11, 2022
NCT05056766 Completed How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement September 1, 2021 September 1, 2022
NCT05077930 Completed Phase 2 Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 January 6, 2022 April 7, 2022
NCT05422326 Completed Phase 2 A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed July 18, 2022 March 24, 2023
NCT05534685 Not yet recruiting N/A Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia September 20, 2022 July 20, 2023
NCT06376084 Not yet recruiting Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC July 24, 2024 February 28, 2028
NCT05592431 Not yet recruiting N/A Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Neonates October 27, 2022 April 30, 2024
NCT06308926 Not yet recruiting Phase 2 MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients July 1, 2024 July 1, 2026
NCT06004440 Recruiting Real World Registry for Use of the Ion Endoluminal System September 21, 2023 August 2027
NCT06149494 Recruiting Phase 2 RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection November 20, 2023 March 30, 2025
NCT06177925 Recruiting Phase 2 A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC December 10, 2023 September 30, 2026
NCT05797246 Recruiting Phase 2 Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) August 2, 2023 November 2, 2026
NCT05907564 Recruiting N/A Aventus Thrombectomy System Pulmonary Embolism Clinical Study September 20, 2023 March 2025
NCT00471250 Recruiting Collection of Lung Fluid and Tissue Samples for Research August 17, 2007
NCT04263038 Recruiting Phase 4 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism May 15, 2020 May 2026
NCT04657120 Recruiting N/A Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy June 1, 2019 May 2024
NCT06266442 Recruiting M. Avium WGS During Mav-PD Treatment May 13, 2024 September 2026
NCT05251467 Recruiting A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF February 28, 2022 September 30, 2023
NCT05493527 Recruiting N/A Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Neonates February 1, 2021 August 30, 2022
NCT05565872 Recruiting N/A Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD October 5, 2022 November 15, 2024
NCT00606788 Suspended N/A Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning November 2005 February 2007
NCT04644315 Terminated Phase 2 A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors May 24, 2021 May 16, 2022
NCT02261350 Terminated Phase 3 Post-hospitalisation Nutritional Support and Gait Speed in COPD January 2014 September 2015
NCT02340299 Terminated N/A Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2 January 1, 2015 December 31, 2017
NCT05153408 Terminated Phase 1 (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC January 13, 2022 December 9, 2022
NCT03982199 Terminated Phase 2 A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older August 1, 2019 May 26, 2023
NCT03142191 Terminated Phase 2 A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis July 26, 2017 December 24, 2021
NCT04371978 Terminated Phase 3 Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 October 1, 2020 May 4, 2021
NCT04133337 Unknown status Phase 1/Phase 2 Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC November 1, 2019 June 2021
NCT03402048 Unknown status Phase 3 The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial July 2012 May 2021
NCT04371796 Unknown status Phase 2 Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC May 10, 2020 December 30, 2021
NCT01055990 Unknown status Phase 2 Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients October 2009 May 2010
NCT02913365 Unknown status Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis October 2012 June 2017
NCT03392129 Unknown status N/A Ai Chi Method for Children With Asthma December 20, 2017 July 20, 2020
NCT01319643 Unknown status Phase 4 Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) December 2009 November 2011
NCT04697446 Unknown status External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC December 1, 2020 October 31, 2021
NCT01353105 Unknown status Phase 4 Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion August 2011 August 2015
NCT03389256 Unknown status Phase 2 Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC December 30, 2018 August 30, 2022
NCT04341610 Withdrawn Phase 1/Phase 2 ASC Therapy for Patients With Severe Respiratory COVID-19 April 20, 2020 April 30, 2021
NCT04842331 Withdrawn Phase 2/Phase 3 PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) September 2021 January 2022
NCT00830427 Withdrawn Phase 2 A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects April 15, 2009 December 31, 2009
MeSH unique ID (MeSH (Medical Subject Headings))
D012140